| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/19/2002 | EP1214303A1 Heterocyclic compounds and methods of use thereof |
| 06/19/2002 | EP1214299A1 Muscarinic antagonists |
| 06/19/2002 | EP1214296A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/19/2002 | EP1214293A1 Non-peptidic cyclophilin binding compounds and their use |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214075A1 POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 06/19/2002 | EP1213975A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds |
| 06/19/2002 | EP0975623B1 Indazole amide compounds as serotoninergic agents |
| 06/19/2002 | EP0973725B1 New 1,7,7-trimethyl-bicyclo 2.2.1]heptane derivatives |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | EP0852497B1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 06/19/2002 | EP0800520B1 Process for the preparation of lamotrigine |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354745A Ethanesulfonyl-piperidine derivatives |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354670A Therapeutic agent comprising botulinum neurotoxin |
| 06/19/2002 | CN1354664A Injectable naltrexone microsphere compositions and their use in reducing consumption of heroinb and alcohol |
| 06/19/2002 | CN1354662A Use of osanetant in pharmaceutical preparation for treatment of mood disorders |
| 06/19/2002 | CN1354655A Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 06/19/2002 | CN1354653A Compressed compositions comprising clarified xanthan gum |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354183A Tumor death induction ligand gene, gene expression protein and its preparation method |
| 06/19/2002 | CN1353990A Preparation for analgesia and anesthesia or curing drug dependence |
| 06/19/2002 | CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine |
| 06/19/2002 | CN1086385C Methanesulphonate salt of arylpiperzine derived from tryptamine and its solvates for pharmaceutical use |
| 06/19/2002 | CN1086299C Chinese medicinal oral liquid for curing nerve injury, neuronal disease and its preparing method |
| 06/19/2002 | CN1086295C External used medicinal liquor |
| 06/19/2002 | CN1086291C Primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases |
| 06/18/2002 | US6407267 Method for the preparation of citalopram |
| 06/18/2002 | US6407255 Chemical synthesis of 1,2,4-triazolinone derivative |
| 06/18/2002 | US6407237 Crystal forms of 9-substituted hypoxanthine derivatives |
| 06/18/2002 | US6407235 Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
| 06/18/2002 | US6407204 Use of conantokins for producing analgesia or for neuoprotection |
| 06/18/2002 | US6407140 Autoimmune diseases, graft versus host disease and organ transplant surgery; pyrazole derivative mixture |
| 06/18/2002 | US6407133 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 06/18/2002 | US6407122 Neuroprotective agents, antiischemic, and hyperglycemic agents; huntington*s, parkinson*s, and alzheimer*s disease;amyotrophic lateral sclerosis treatment; nervous system and brain disorders |
| 06/18/2002 | US6407120 Administering pyridinylacetamide or phenylacetamide derivative to treat cardiovascular, eating, sexual, brain, nervous system, gastrointestinal, urogenital, psychological, and respiratory system disorders |
| 06/18/2002 | US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/18/2002 | US6407111 Phenyl substituted pyridine and benzene derivatives |
| 06/18/2002 | US6407109 Antiepiletic, antidepressant, and anxiolytic agents; psychological and nervous system disorders |
| 06/18/2002 | US6407106 For therapy of inflammatory disturbances of the gastrointestinal tract |
| 06/18/2002 | US6407099 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 06/18/2002 | US6407095 Treating nicotinic receptor, gastrointestinal, nervous system, psychological, and brain disorders |
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407093 (3,4-dihydro-2h-benzothiopyran-4-yl)-homopiperazine derivatives; antiischemic agents; alzheimer*s and parkinson*s disease, aids related dementia, multiple sclerosis, amyotrophic lateral sclerosis |
| 06/18/2002 | US6407092 Tetracyclic azepinoindole compounds |
| 06/18/2002 | US6407088 Method of analgesia |
| 06/18/2002 | US6407076 Adenosine analogues and related method of treatment |
| 06/18/2002 | US6407064 Aminoalcohol derivative and medicament comprising the same |
| 06/18/2002 | US6407060 Method for enhancing functional recovery following central nervous system ischemia or trauma |
| 06/18/2002 | US6407058 Phosphorylation of serine or threonine |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | CA2356812A1 Tnf-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/18/2002 | CA2238140C Imidazole, triazole and tetrazole derivatives |
| 06/18/2002 | CA2235053C Novel amino compounds of 6,7,8,9-tetrahydro-cyclopenta[a]naphthalene and 2,3-dihydro-cyclopenta[e]indene, process for their preparation and pharmaceutical compositions containing them |
| 06/14/2002 | WO2001041709A2 Methods for treating cell death diseases and inflammation |
| 06/14/2002 | CA2393722A1 Methods for treating cell death diseases and inflammation |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046424A2 Fibroblast growth factors |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein |
| 06/13/2002 | WO2002046385A2 Enzymes |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
| 06/13/2002 | WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide |
| 06/13/2002 | WO2002046230A2 G-protein coupled receptors |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | WO2002046193A2 Heterocyclic ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046192A2 Thioether substituted imidazoquinolines |
| 06/13/2002 | WO2002046191A2 Urea substituted imidazoquinoline ethers |
| 06/13/2002 | WO2002046190A2 Sulfonamido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046189A2 Aryl ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046188A2 Amido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 06/13/2002 | WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | WO2002046180A1 Klainetin and derivatives thereof, method for their production and the use of the same |
| 06/13/2002 | WO2002046178A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
| 06/13/2002 | WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046168A1 Therapeutic benzimidazole compounds |
| 06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 06/13/2002 | WO2002046164A1 Therapeutic compounds |
| 06/13/2002 | WO2002046163A2 Quinoline derivatives and their use as anti-epileptics |
| 06/13/2002 | WO2002046162A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 06/13/2002 | WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/13/2002 | WO2002046154A1 Peroxisome proliferator activated receptor d activators |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |